Su Jae Yang

Su Jae Yang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit autotaxin activity. His work is crucial for addressing various diseases related to this enzyme.

Latest Patents

Su Jae Yang holds a patent for a piperidine derivative and a pharmaceutical composition for inhibiting autotaxin. This patent includes a piperidine derivative compound, its hydrates, solvates, and pharmaceutically acceptable salts. The composition is designed for the prevention or treatment of diseases associated with autotaxin activity, such as fibrotic diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, metabolic diseases, cancer, and more. The piperidine derivative exhibits excellent inhibitory activity against autotaxin, making it a valuable asset in medical treatments.

Career Highlights

Su Jae Yang is affiliated with Nextgen Bioscience Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has the potential to impact a wide range of medical conditions, showcasing his dedication to improving health outcomes.

Collaborations

Some of his notable coworkers include Bong Yong Lee and Young Ah Shin. Their collaboration contributes to the advancement of research and development in their field.

Conclusion

Su Jae Yang is a key figure in the pharmaceutical industry, with a focus on developing innovative solutions for diseases related to autotaxin. His contributions are paving the way for new treatments and improving patient care.

Profile summary based on public USPTO records.